At present, the prevalence of type 2 diabetes mellitus (DM-2) is steadily increasing. Surgical methods of treatment (restriction and shunting operations) occupy a leading position in the treatment and correction of this pathology due to the highest metabolic efficiency. Each of the existing shunting operations (gastric gastrointestinal, biliopanсreatic bypass (PBS)), in turn, is used in various modifications. Among the operations of BPS are known modifications of Scopinaro, modification of Hess-Marceau and SADI appeared in recent years (duode-iliac bypass with gastric resection and one anastomosis). The SADI modification, like other types of BPS, allows to effectively reduce excess body mass (MT), contributes to the normalization of carbohydrate and lipid exchanges, which leads to failure/decrease in the frequency of insulin therapy and sugars treatment. The potential benefits of SADI include reduced operation time, no mesentery defects, which is intended to reduce the frequency of internal herniation. According to researchers, SADI also leads to fewer complications both in the early and late postoperative period. Given the high effectiveness of this treatment, more and longer individual observations are needed to further assess the long-term effectiveness of the treatment and its compatibility with previously known methods
At present, the prevalence of type 2 diabetes mellitus (DM-2) is steadily increasing. Surgical methods of treatment (restriction and shunting operations) occupy a leading position in the treatment and correction of this pathology due to the highest metabolic efficiency. Each of the existing shunting operations (gastric gastrointestinal, biliopanсreatic bypass (PBS)), in turn, is used in various modifications. Among the operations of BPS are known modifications of Scopinaro, modification of Hess-Marceau and SADI appeared in recent years (duode-iliac bypass with gastric resection and one anastomosis). The SADI modification, like other types of BPS, allows to effectively reduce excess body mass (MT), contributes to the normalization of carbohydrate and lipid exchanges, which leads to failure/decrease in the frequency of insulin therapy and sugars treatment. The potential benefits of SADI include reduced operation time, no mesentery defects, which is intended to reduce the frequency of internal herniation. According to researchers, SADI also leads to fewer complications both in the early and late postoperative period. Given the high effectiveness of this treatment, more and longer individual observations are needed to further assess the long-term effectiveness of the treatment and its compatibility with previously known methods
| № | Муаллифнинг исми | Лавозими | Ташкилот номи |
|---|---|---|---|
| 1 | Tavasharov B.N. | PhD | Tashkent Medical Academy |
| 2 | Yusupova T.A. | MD | Tashkent Medical Academy |
| № | Ҳавола номи |
|---|---|
| 1 | 1.Звенигородская Л.А. Эндоканнабиноидная система, пищевая аддикция, морбидное ожирение. // Consiliummedicum. Гастроэнтерология. –2014. Т. 16. -No8. –С. 67-72. 2.Buschur ME, Smith D, Share D, et al. The burgeoning epidemic of morbid obesity in patients undergoing percutaneous coronary intervention: insight from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium. J Am Coll Cardiol. 2013;62(8):685-691. doi: 10.1016/j.jacc.2013.06.0043.Наврузов, Б., Убайдуллаев, З., Ортикбоев, Ф., & Усмонов, Б. (2023). УЛУЧШЕНИЕ РЕЗУЛЬТАТОВ ЛЕЧЕНИЕ НЕДОСТАТОЧНОСТИ АНАЛЬНОГО СФИНКТЕРА ПОСЛЕ ОПЕРАЦИИ ПО ПОВОДУ ЭКСТРО-И ТРАНС СФИНКТЕРНЫХ СВИЩЕЙ. Евразийский журнал медицинских и естественных наук, 3(3), 97-103.4.Агзамова, М. Н., & Усмонбекова, Г. У. (2018). Эффективность комплексного лечения больных острым перитонитом. Молодой ученый, (18), 135-137.5.Ortiqboyev, F. (2023). TO'QIMA MUHANDISLIK KONSTRUKTSIYALARI, TERI EKVIVALENTLARI VA ULARNI TROFIK YARA KASALIGINI DAVOLASHDA FOYDALANISH. Евразийский журнал медицинских и естественных наук, 3(8), 43-526.Мирзахмедов, М. М. (2012). Хирургическая коррекция и профилактика послеоперационных осложнений болезни Гиршпрунга у взрослых. Український журнал хірургії, (3), 30-33.7.Stunkard A. Obesity: risk factors, consequences and control. Med J Aust. 1988;148:S21-28.8.Stunkard AJ. Current views on obesity. Am J Med. 1996;100(2):230-236. doi: 10.1016/s0002-9343(97)89464-89.Asensio C, Cettour-Rose P, Theander-Carrillo C, et al. Changes in glycemia by leptin administration or high-fat feeding in rodent models of obesity/ type 2 diabetes suggest a link between resistin expression and control of glucose homeostasis. Endocrinology. 2004;145(5):2206-2213. doi: 10.1210/en.2003-167910.Dominiczak MH. Obesity, glucose intolerance and diabetes andtheir links to cardiovascular disease. Implications for laboratory medicine. Clin Chem Lab Med. 2003;41(9):1266-1278. doi: 10.1515/CCLM.2003.19411.Will JC, Williamson DF, Ford ES, et al. Intentional Weight Loss and 13-Year Diabetes Incidence in Overweight Adults. American Journal of Public Health. 2002;92(8):1245-1248. doi: 10.2105/ajph.92.8.124512.Look ARG, Wing RR, Bolin P, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369(2):145-154. doi: 10.1056/NEJMoa121291413.James WP, Caterson ID, Coutinho W, et al. Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. N Engl J Med. 2010;363(10):905-917. doi: 10.1056/NEJMoa100311414.Наврузов, Б., Тешаев, О., Холов, Х., Убайдуллаев, З., & Ортикбоев, Ф. (2023). НЕДОСТАТОЧНОСТЬ СФИНКТЕРА ПРИ ОПЕРАЦИИ НА ЭКСТРАСФИНКТЕРНЫХ СВИЩЕЙ (ОБЗОР ЛИТЕРАТУРЫ). Евразийский журнал медицинских и естественных наук, 3(4), 55-67.15.Gazet JC, Pilkington TR. Surgery of morbid obesity. Bmj. 1987;295(6590):72-73. doi: 10.1136/bmj.295.6590.7216.Sobel RJ, Gert B. Guidelines for surgery for morbid obesity. Am J ClinNutr. 1987;45(4):797-799.17.Mirxaydarovich, D. M. M., & Dilshod o’g’li, O. F. (2023). The Optimum Surgical Methods at Disease Hirschsprung’s in Adults. Texas Journal of Medical Science, 20, 53-56.18.Sjostrom L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307(1):56-65. doi: 10.1001/jama.2011.191419.Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastricbypass surgery. N Engl J Med. 2007;357(8):753-761. doi: 10.1056/NEJMoa06660320.Buchwald H. The evolution of metabolic/bariatric surgery. Obes Surg. 2014;24(8):1126-1135. doi: 10.1007/s11695-014-1354-321.Angrisani L, Santonicola A, Hasani A, et al. Five-year results of laparoscopic sleeve gastrectomy: effects on gastroesophageal reflux disease symptoms and co-morbidities. SurgObesRelatDis. 2016;12(5):960-968.22.Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery worldwide 2013. Obes surg. 2015;25(10):1822-1832.23.Яшков Ю.И., Никольский А.В, Бекузаров Д.К, и др. Cемилетний опыт применения операции билиопанкреатического отведения в модификации Hess-Marceauв лечении морбидного ожирения и сахарного диабета 2 типа // Ожирение и метаболизм. –2012. –Т. 9. –No2. –C. 43-48. doi: 10.14341/omet2012243-4824.Fisher BL, Schauer P. Medical and surgical options in the treatment of severe obesity. The American Journal of Surgery. 2002;184(6):S9-S16. doi: 10.1016/s0002-9610(02)01173-x25.Rutledge R. The mini-gastric bypass: experience with the first 1,274 cases. Obes Surg. 2001;11(3):276-280. doi: 10.1381/09608920132133658426.Arterburn DE, Courcoulas AP. Bariatric surgery for obesity and metabolic conditions in adults. BMJ. 2014;349:g3961. doi: 10.1136/bmj.g396127.Scopinaro N, Gianetta E, Civalleri D, et al. Bilio-pancreatic bypass for obesity: II. Initial experience in man. Br J Surg. 1979;66(9):618-620. doi: 10.1002/bjs.180066090628.Дедов И.И. Морбидное ожирение / под редакцией Дедова И.И. –М.: ООО МИА; 2014. 29.Hess DS, Hess DW. Biliopancreatic diversion with a duodenal switch. Obes Surg. 1998;8(3):267-282. doi: 10.1381/09608929876555447630.Marceau P, Biron S, St Georges R, et al. Biliopancreatic Diversion with Gastrectomy as Surgical Treatment of Morbid Obesity. ObesSurg. 1991;1(4):381-386. doi: 10.1381/09608929176556076431.DeMeester TR, Fuchs KH, Ball CS, et al. Experimental and Clinical Results with Proximal End-to-End Duodenojejunostomy for Pathologic Duodenogastric Reflux. AnnSurg. 1987;206(4):414-426. doi: 10.1097/00000658-198710000-0000332.Sanchez-Pernaute A, Rubio MA, Cabrerizo L, et al. Single-anastomosis duodenoileal bypass with sleeve gastrectomy (SADI-S) for obese diabetic patients. Surg Obes Relat Dis. 2015;11(5):1092-1098. doi: 10.1016/j.soard.2015.01.02433.Hess DS, Hess DW, Oakley RS. The biliopancreatic diversion with the duodenal switch: results beyond 10 years. Obes Surg. 2005;15(3):408-416. doi: 10.1381/096089205357669534.Marceau P, Biron S, Hould F-S, et al. Duodenal Switch: Long-Term Results. ObesSurg. 2008;17(11):1421-1430. doi: 10.1007/s11695-008-9435-935.Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248-256 e245. doi: 10.1016/j.amjmed.2008.09.04136.Prachand VN, Ward M, Alverdy JC. Duodenal switch provides superior resolution of metabolic comorbidities independent of weight loss in the superobese (BMI > or = 50 kg/m2) compared with gastric bypass. J Gastrointest Surg. 2010;14(2):211-220. doi: 10.1007/s11605-009-1101-637.SovikTT, Aasheim ET, Taha O, et al. Weight loss, cardiovascular risk factors, and quality of life after gastric bypass and duodenal switch: a randomized trial. Ann Intern Med. 2011;155(5):281-291. 38.Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg. 2013;23(4):427-436. doi: 10.1007/s11695-012-0864-039.Scopinaro N, Adami GF, Marinari GM, et al. Biliopancreatic Diversion. World J Surg. 1998;22(9):936-946. doi: 10.1007/s00268990049740.Sanchez-PernauteA, Herrera MA, Perez-Aguirre ME, et al. Single anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S). One to three-year follow-up. Obes Surg. 2010;20(12):1720-1726. doi: 10.1007/s11695-010-0247-341.Frenken M, Cho EY. Metabolic intestinal bypass surgery for type 2 diabetes in patients with a BMI <35 kg/m2: comparative analysis of 16 patients undergoing either BPD, BPD-DS, or RYGB. Obes Facts. 2011;4 Suppl1:13-17. doi: 10.1159/00032703842.Наврузов, С. Н., Мирзахмедов, М. М., Наврузов, Б. С., & Ахмедов, М. А. (2013). Особенности клинического течения и выбор способа хирургического лечения болезни Гиршпрунга у взрослых. Новости хирургии, 21(2), 54-60.43.Bloomberg RD, Fleishman A, Nalle JE, et al. Nutritional deficiencies following bariatric surgery: what have we learned? Obes Surg. 2005;15(2):145-154. doi: 10.1381/096089205326826444.Ершова Е.В., Яшков Ю.И. Состояние углеводного и липидного обмена у пациентов с ожирением и сахарным диабетом 2 типа после билиопанкреатического шунтирования // Ожирение и метаболизм. –2013. –Т. 10. –No3. –C. 28-36. doi: 10.14341/2071-8713-386245.Topart P, Becouarn G, Ritz P. Comparative early outcomes of three laparoscopic bariatric procedures: sleeve gastrectomy, Roux-en-Y gastric bypass, and biliopancreatic diversion with duodenal switch. Surg Obes Relat Dis. 2012;8(3):250-254. doi: 10.1016/j.soard.2011.05.01246.Chang SH, Stoll CR, Song J, et al. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012. JAMA Surg. 2014;149(3):275-287. doi: 10.1001/jamasurg.2013.365447.Inabnet WB, 3rd, Winegar DA, Sherif B, Sarr MG. Early outcomes of bariatric surgery in patients with metabolic syndrome: an analysis of the bariatric outcomes longitudinal database. J Am Coll Surg. 2012;214(4):550-556; 48.Мирзахмедов, М. М. (2013). Опыт лечения болезни Гиршпрунга у взрослых. Український журнал хірургії, (2), 89-94.49.Reoch J, Mottillo S, Shimony A, et al. Safety of laparoscopic vs open bariatric surgery: a systematic review and meta-analysis. Arch Surg. 201150.Mirxaydarovich, D. M. M., & Dilshod o’g’li, O. F. (2023). The Optimum Surgical Methods at Disease Hirschsprung’s in Adults. Texas Journal of Medical Science, 20, 53-56.51.Michaud A, Marchand GB, Nadeau M, et al. Biliopancreatic Diversion with Duodenal Switch in the Elderly: Long-Term Results of a Matched-Control Study. Obes surg. 2016;26(2):350-360.52.Gracia JA, Martinez M, Elia M, et al. Obesity surgery results depending on technique performed: long-term outcome. Obes Surg. 2009;19(4):432-438. doi: 10.1007/s11695-008-9762-x53.Smith MD, Patterson E, Wahed AS, et al. Thirty-day mortality after bariatric surgery: independently adjudicated causes of death in the longitudinal assessment of bariatric surgery. Obes Surg. 2011;21(11):1687-1692. 54.Birkmeyer JD, Finks JF,O'Reilly A, et al. Surgical skill and complication rates after bariatric surgery. N Engl J Med. 2013;369(15):1434-1442. 55.Biertho L, Lebel S, Marceau S, et al. Laparoscopic sleeve gastrectomy: with or without duodenal switch? A consecutive series of 800 cases. Dig Surg. 2014;31(1):48-54. doi: 10.1159/00035431356.Rabl C, Peeva S, Prado K, et al. Early and late abdominal bleeding after Rouxen-Y gastric bypass: sources and tailored therapeutic strategies. Obes Surg. 2011;21(4):413-420. doi: 10.1007/s11695-011-0354-957.Kumar N, Thompson CC. Endoscopic management of complications after gastrointestinal weight loss surgery. Clin Gastroenterol Hepatol. 2013;11(4):343-353. doi: 10.1016/j.cgh.2012.10.04358.Coblijn UK, Goucham AB, Lagarde SM, et al. Development of ulcer disease after Roux-en-Y gastric bypass, incidence, risk factors, and patient presentation: a systematic review. Obes Surg. 2014;24(2):299-309. 59.Pories WJ, Swanson MS, MacDonald KG, et al. Who Would Have Thought It? An Operation Proves to Be the Most Effective Therapy for Adult-Onset Diabetes Mellitus. Ann Surg. 1995;222(3):339-352. 60.DeMaria EJ, Sugerman HJ, Kellum JM, et al. Results of 281 Consecutive Total Laparoscopic Roux-en-Y Gastric Bypasses to Treat Morbid Obesity. Ann Surg. 2002;235(5):640-647. doi: 10.1097/00000658-200205000-0000561.Rubino F, Gagner M, Gentileschi P, et al. The Early Effect of the Roux-en-Y Gastric Bypass on Hormones Involved in Body Weight Regulation and Glucose Metabolism. Ann Surg. 2004;240(2):236-242. 62.Rubino F, Marescaux J. Effectof duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg. 2004;239(1):1-11. doi: 10.1097/01.sla.0000102989.54824.fc63.Kawada T. Bariatric Surgery in Patients With Type 2 Diabetes Mellitus. Ann Surg. 2015. doi: 10.1097/SLA.000000000000137964.Cho EY, Kemmet O, Frenken M. Biliopancreatic diversion with duodenal switch in patients with type 2 diabetes mellitus: is the chance of complete remission dependent on therapy and duration of insulin treatment? Obes Facts. 2011;4 Suppl 1:18-23. doi: 10.1159/00032703765.Buchwald H, Rucker R. The rise and fall of jejunoileal bypass. Surgery of the small intestine. Appleton Century Crofts, Norwalk, CT. 1987:529-541.66.Мирзахмедов, М. М. (2012). Современные аспекты диагностики и лечения болезни Гиршпрунга у взрослых. In Контактная информация организационного комитета конференции (p. 44).67.Colquitt JL, Pickett K, Loveman E, Frampton GK. Surgery for weight loss in adults. Cochrane Database Syst Rev. 2014(8):CD003641. 68.Renard E. Bariatric surgery in patients with late-stage type 2 diabetes: expected beneficial effects on risk ratio and outcomes. Diabetes Metabol. 2009;35(6):564-568. doi: 10.1016/s1262-3636(09)73467-6 |